Table 1 Clinicopathological characteristics of esophageal cancer patients
Risk factors | Number of patient | % |
|---|---|---|
Total | 105 | |
Age | ||
< 60 | 33 | 32.1 |
≥ 60 | 72 | 67.9 |
Gender | ||
Male | 77 | 73.3 |
Female | 28 | 26.7 |
Histological type | ||
Squamous cell carcinoma | 105 | 100 |
Pathological type | ||
Protuberant type | 1 | 1.0 |
Ulcerative type | 62 | 59.0 |
Medullary type | 36 | 34.3 |
Mushroom type | 6 | 5.7 |
T stage | ||
T1 | 6 | 5.7 |
T2 | 12 | 11.4 |
T3 | 84 | 80.0 |
T4 | 3 | 2.9 |
N stage | ||
N0 | 47 | 44.8 |
N1 | 32 | 30.5 |
N2 | 22 | 21.0 |
N3 | 4 | 3.8 |
AJCC clinical stage | ||
Stage I | 5 | 4.8 |
Stage II | 47 | 44.8 |
Stage III | 53 | 50.5 |
Pathological grading | ||
I | 29 | 27.6 |
II | 67 | 63.8 |
III | 9 | 8.6 |
Ki67 expression | ||
< 14% | 22 | 20.9 |
≥ 14% | 83 | 79.1 |
p53 expression | ||
Strongly | 67 | 63.8 |
Weakly | 38 | 36.2 |
BRAF expression | ||
Strongly | 87 | 82.9 |
Weakly | 18 | 17.1 |